Učitavanje...
Prevention of BMS‐777607‐induced polyploidy/senescence by mTOR inhibitor AZD8055 sensitizes breast cancer cells to cytotoxic chemotherapeutics
Targeted inhibition of MET/RON signaling by tyrosine kinase inhibitor BMS‐777607 for cancer treatment is currently under clinical trials. We have previously shown that BMS‐777607 induces chemoresistance in vitro by causing polyploidy, which hampers therapeutic efficacy. Here, we studied polyploidy‐a...
Spremljeno u:
| Izdano u: | Mol Oncol |
|---|---|
| Glavni autori: | , , , , , |
| Format: | Artigo |
| Jezik: | Inglês |
| Izdano: |
John Wiley and Sons Inc.
2014
|
| Teme: | |
| Online pristup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5528636/ https://ncbi.nlm.nih.gov/pubmed/24444656 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.molonc.2013.12.014 |
| Oznake: |
Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!
|